The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

Following three years of internal development, Expedition Medicines is taking flight. The company is supported by a $50 ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...

Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to proprietary structural data to train a large language model. Each of the ...

Oct 1 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab, Takeda Pharmaceuticals (4502.T), opens new tab and Astex Pharmaceuticals are coming together to share proprietary data for training an ...

A researcher has proposed a more targeted approach to AI drug discovery, which includes a rigorous evaluation protocol.

(Reuters) -Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from ...